Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
65.80    0.90 (1.39%)
Bid:
65.40
Ask:
65.60
Spread: 0.20 (0.306%)
Market Cap: £581.30m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Webinar on ESG & Impact

12 Oct 2023 10:20

RNS Number : 9241P
IP Group PLC
12 October 2023
 

FOR RELEASE ON

12 October 2023

IP Group - Webinar on ESG & Impact

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces that it will hold a webinar on ESG and impact entitled "ESG Forward - our approach to impact" on Thursday November 16 2023.

 

Our Head of ESG, Bran Pathman?ban, will be joined by our CEO Greg Smith and CFOO David Baynes to discuss the Group's approach to ESG and impact, as well as the broader challenges of providing a meaningful narrative around impact.

 

We're delighted to be joined by special guest Alex Edmans, Professor of Finance at London Business School. Alex has a PhD from MIT as a Fulbright Scholar and was previously a tenured professor at Wharton and an investment banker at Morgan Stanley. He serves as non-executive director of the Investor Forum, on the World Economic Forum's Global Future Council on Responsible Investing, and on Royal London Asset Management's Responsible Investment Advisory Committee.

 

Further details of the event, which will start at 9am, and how to register can be found on the events section of our website: https://www.ipgroupplc.com/news-and-events/events.

 

The update will be hosted live via the Investor Meet Company platform. Questions can be submitted in advance of the event via the Investor Meet Company Platform up to 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free via: https://www.investormeetcompany.com/ip-group-plc/register-investor. Investors who already follow IP Group plc on the Investor Meet Company platform will automatically be invited.

 

No material new information will be released by the Company during the presentation.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Vic Wallin

Alex Donaldson

+44 (0) 7973 823119

+44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. Athe most active UK based, early stage science investorwe develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutionsOur specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAVLLBFXBLLFBE
Date   Source Headline
30th Jan 20267:00 amRNSHolding(s) in Company
29th Jan 20267:00 amRNSHolding(s) in Company
20th Jan 202612:36 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSDirectorate change
14th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20266:25 pmRNSHolding(s) in Company
7th Jan 20262:06 pmRNSPulmocide announces termination of Phase 3 study
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20255:26 pmRNSHolding(s) in Company
4th Dec 20254:13 pmRNSHolding(s) in Company
1st Dec 20255:37 pmRNSTotal Voting Rights
20th Nov 20257:00 amRNSCompletion of share buyback programme
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20251:10 pmRNSArtios completes oversubscribed $115m financing
14th Nov 20255:47 pmRNSTransaction in Own Shares
14th Nov 20258:20 amRNSHolding(s) in Company
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20254:09 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20254:45 pmRNSHolding(s) in Company
10th Nov 20256:02 pmRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20254:51 pmRNSHolding(s) in Company
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20255:14 pmRNSHolding(s) in Company
4th Nov 20256:23 pmRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20255:25 pmRNSTotal Voting Rights
31st Oct 20255:19 pmRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20255:27 pmRNSTransaction in Own Shares
28th Oct 20256:06 pmRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20255:31 pmRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20255:30 pmRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20255:59 pmRNSTransaction in Own Shares
16th Oct 20255:45 pmRNSTransaction in Own Shares
15th Oct 20255:20 pmRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20256:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.